GLP-1 drugs don't work for everyone. But personalized obesity care in the future might

Injectable GLP-1 drugs have been a game-changer for many people with obesity. But as researchers discover why the medicines fail for others, they are gaining insights about the complexity of the condition.

As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of obesity. They foresee a future of personalized obesity medicine similar to the way cancer is treated now.

(Image credit: Tatsiana Volkava)